Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice

Methods

Volumn 49, Issue 4, 2009, Pages 309-315

  Acevedo, Reinaldo ^a   Callicó, Adriana ^a   del Campo, Judith ^a   González, Elizabeth ^a   Cedré, Bárbara ^a   González, Lissette ^b   Romeu, Belkis ^a   Zayas, Caridad ^a   Lastre, Miriam ^a   Fernández, Sonsire ^a   Oliva, Reynaldo ^a   García, Luis ^a   Pérez, José Luis ^a   Pérez, Oliver ^a  

^a FINLAY INSTITUTE   (Cuba)

^b UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Adjuvant; Cochleates; Intranasal; Mice; Mucosal; Proteoliposomes; Vaccine; Vesicle; Vibrio cholerae

Indexed keywords

ADJUVANT FINLAY COCHLEATE 2; ANTIGEN; BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; LIVE VACCINE; MANNOSE SENSITIVE HEMAGGLUTININ ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN U; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIALYSIS; FECES; FEMALE; IMMUNE RESPONSE; IMMUNOCHEMISTRY; MICROSCOPY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; SALIVA; VIBRIO CHOLERAE; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ANIMALS; DEOXYCHOLIC ACID; EDETIC ACID; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; PROTEOLIPIDS; VIBRIO CHOLERAE O1;

MUS; VIBRIO CHOLERAE;

EID: 70350726779     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2009.03.027     Document Type: Article

References (61)

1. Gould-Forgerite S., Kheiri M.T., Zhang F., Wang Z., Scolpino A.J., Feketeova E., et al. Adv. Drug Deliv. Rev. 32 (1998) 273-287
2. O. Pérez, G. Bracho, M. Lastre, G. Sierra, C. Campa, N. Mora et al., Método de obtención de estructuras cocleares, composiciones vacunales y adyuvantes basados en estructuras cocleares, OCPI23313 (Cuban Office for Intellectual Property), 2008.
3. Pérez O., Lastre M., Cabrera O., del Campo J., Bracho G., Cuello M., et al. Scand. J. Immunol. 66 (2007) 271-277
4. del Campo J., Lastre M., Bracho G., Rodríguez T., Gil D., Zayas C., et al. Vaccine 24 S2 (2006) 50-51
5. Mintz E.D., Tauxe R.V., and Levine M.M. The global resurgence of cholera. In: Noah N., and O'Mahony M. (Eds). Communicable Disease: Epidemiology and Control (1998), John Wiley & Sons, Chichester, England 63-104
6. Tacket C.O., Cohen M.B., Wasserman S.S., Losonsky G., Livio S., Kotloff K., et al. Infect. Immun. 67 (1999) 6341-6345
7. Sack D., Sack R.B., Nair G.B., Nair A.K., and Siddique A.K. Lancet 363 (2004) 223-233
8. Levine M.M., and Kaper J.B. Live oral cholera vaccine: from principle to product. Bull. Inst. Pasteur 93 (1995) 243-253
9. Sanchez J.L., Trofa A.F., Taylor D.N., Kuschner R.A., DeFraites R.F., Craig S.C., et al. J. Infect. Dis. 167 6 (1993) 1446-1449
10. Sanchez J.L., Vasquez B., Begue R.E., Meza R., Castellares G., Cabezas C., et al. Lancet 344 8932 (1994) 1273-1276
11. Richie E.E., Punjabi N.H., Sidharta Y.Y., Peetosutan K.K., Sukandar M.M., Wasserman S.S., et al. Vaccine 18 (2000) 2399-2410
12. Viret J.F., Dietrich G., and Favre D. Vaccine 22 (2004) 2457-2469
13. Trach D.D., Cam P.D., Ke N.T., Rao M.R., Dinh D., Hang P.V., et al. Bull. WHO 80 (2002) 2-8
14. Mahalanabis D., Lopez A.L., Sur D., Deen J., Manna B., Kanungo S., et al. PLoS ONE 3 6 (2008) e2323
15. Qadri F.M., Chowdhury I., Faruque S.M., Salam M.A., Ahmed T., Begum Y.A., et al. Vaccine 25 (2007) 231-238
16. García L., Díaz J.M., García H., Rodríguez B.L., Fernández R., Año G., et al. Infect. Immun. 73 5 (2005) 3018-3024
17. Talavera A., Año G., Pino Y., Castaño J., Uribarri E., Riverón L., et al. Vaccine 24 (2006) 3381-3387
18. Chaignat C.L. Exp. Rev. Vaccines 7 4 (2008) 403-405
19. Osek J., Svennerholm A.M., and Holmgren J. Infect. Immun. 60 (1992) 4961-4964
20. Chatterjee S.N., and Chaudhuri K. Biochim. Biophys. Acta. 1762 (2006) 1-16
21. Sperandio V., Giron J.A., Silveira W.D., and Kaper J.B. Infect. Immun. 63 (1995) 4433-4438
22. Gupta R.K., Szu S.C., Finkelstein R.A., and Robbins J.B. Infect. Immun. 60 (1992) 3201-3208
23. Cabrera O., Martinez M.E., Cuello M., Soto C.R., Valmaseda T., Cedre B., et al. Vaccine 24 S2 (2006) 74-75
24. Pérez J.L., González Y., Año G., Cedré B., Valmaseda T., Álvarez M., et al. VacciMonitor 15 1 (2006) 1-7
25. Pérez J.L., Acevedo R., Fernández Y., Cedré B., Año G., González L., et al. Vaccine (2008) 10.1016/j.vaccine.2008.10.052
26. Silva A.J., Mohan A., and Benitez J.A. Vaccine 21 (2003) 4715-4721
27. Mosley W.H., McCormack W.M., Ahmed A., Chowdhury A.K.M., and Barui R.K. Bull. World Health Organ. 40 (2003) 187-197
28. Hase C.C., Thai L.S., Finkelstein M.B., Mar V.L., Burnette W.N., Kaslow H.R., et al. Infect. Immun. 62 (1994) 3051-3055
29. Gil D., Bracho G., Zayas C., del Campo J., Acevedo R., Toledo A., et al. Vaccine 24 S2 (2006) 92-93
30. Lowry O., Rosebrough H., Farr A., and Randall R. A protein measurement with the folin-phenol reagent. Biol. Chem. 193 (1951) 265-275
31. Pérez J.L., Fernández Y., Aranguren Y., Alvarez M., Acevedo R., Pérez O., and García .L. VacciMonitor 16 1 (2007) 17-22
32. Fiske C.N., and Subarrow Y. J. Biol. Chem. 66 (1925) 375
33. Laemmli N.K. Nature 227 (1970) 680-685
34. Falero G., Rodriguez B.L., Valmaseda T., Perez M.E., Perez J.L., Fando R., et al. Hybridoma 17 1 (1998) 63-67
35. Año G., Garcia H., Valmaceda T., Cedre B., Pino Y., Ancheta O., et al. Biotechnol. Apl. 20 1 (2003) 9-13
36. Falero G., Rodríguez I., Susarte E., Otero O., Fando R., Nuñez N., et al. Rev. CNIC Cienc. Biol. 13 3 (2007) 15-19
37. Burnette W.N. Anal. Biochem. 112 (1980) 192-200
38. Benitez J., García L., Silva A., Garcia H., Fando R., Cedré B., et al. Infect. Immun. 67 (1999) 539-545
39. Schild S., Nelson E.J., and Camilli A. Infect. Immun. 76 10 (2008) 4554-4563
40. Bracho G., Lastre M., del Campo J., Zayas C., González D., Gil D., et al. Vaccine 24 S2 (2006) 30-31
41. Zayas C., Bracho G., Lastre M., González D., Gil D., Acevedo R., et al. Vaccine 24 S2 (2006) 94-95
42. O. Pérez, G. Bracho, M. Lastre, G. Sierra, C. Campa, N. Mora et al., Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof, EP 1602360 and US 20060134134 A1, 2005.
43. Miller V.L., and Mekalanos J.J. J. Bacteriol. 170 (1988) 2575-2583
44. Sperandio V., Giron J.A., Silveira W.D., and Kaper J.B. Infect. Immun. 63 (1995) 4433-4438
45. Apter F.M., Michetti P., Winner L.S., Mack J.A., Mekalanos J.J., and Neutra M.R. Infect. Immun. 61 (1993) 5279-5285
46. Benenson A.S., Mosley W.H., Fahimuddin M., and Oseasohn R.O. Bull. World Health Organ. 38 3 (1968) 359-372
47. Winner L., Mack J., Weltzin R., Mekalanos J.J., Kraehenbuhl J.P., and Neutra M.R. Infect. Immun. 59 (1968) 977-982
48. Svennerholm A.M., and Holmgren J. Infect. Immun. 13 (1976) 735-740
49. Zughaier S.M., Zimmer S.M., Datta A., Carlson R.W., and Stephens D.S. Infect. Immun. 73 5 (2005) 2940-2950
50. Finn T.M., Reiser J., Germanier R., and Cryz S.J. Infect. Immun. 55 4 (1987) 942-946
51. Fries L.F., Montemarano A.D., Mallett C.P., Taylor D.N., Hale T.L., and Lowell G.H. Infect. Immun. 69 7 (2001) 4545-4553
52. Espuelas S., Irache J.M., and Gamazo C. Inmunología 24 2 (2005) 208-223
53. Matsunaga Y., Wakatsuki Y., Tabata Y., Kawasaki H., Usui T., Yoshida M., et al. Vaccine 19 4-5 (2000) 579-588
54. L. David, Mucosal Adjuvants. St. George's Vaccine Institute, UK, 2008. Available from: .
55. O'Hagan D.T. Vaccine Adjuvants. Preparation Methods and Research Protocols (2000), Humana Press, Inc., Totowa, NJ
56. Baumann U., Göcke K., Gewecke B., Freihorst J., and Von Specht B.U. Respir. Res. 8 1 (2007) 57
57. Mann J., Acevedo R., del Campo J., Perez O., and Ferro V. Expert Rev. Vaccines 8 1 (2009)
58. Johansen F.E., Baekkevold E.S., Carlsen H.S., Farstad I.N., Soler D., and Brandtzaeg P. Blood 106 2 (2005) 593-600
59. Brandtzaeg P. Vaccine 25 30 (2007) 5467-5484
60. Drago-Serrano M.E., Manjarréz H.A., Gavilanes S., and del Rosario T. Rev. Latinoam. Microbiol. 46 1-2 (2004) 17-23
61. Mallett C.P., Hale T.L., Kaminski R.W., Larsen T., Orr N., Cohen D., et al. Infect. Immun. 63 6 (1995) 2382-2386